Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C P Lau

Showing results (31-40 of 287) with videos related to

Pageof 29
Sort By:
British Journal of Clinical Pharmacology|April 6, 1999
Fosinopril reduces left ventricular mass in untreated hypertensive patients: a controlled trialB M Cheung, C P Lau
The American Journal of Cardiology|November 1, 1988
Role of left ventricular function and Doppler-derived variables in predicting hemodynamic benefits of rate-responsive pacingC P Lau, A J Camm
Chinese Medical Journal|March 27, 2001
Atrial sensing and pacing with a single pass ventricular leadH F Tse, C P Lau
Current Cardiology Reports|October 17, 2001
Should all implantable cardioverter defibrillators for ventricular arrhythmias be dual-chamber devices?K L Lee, C P Lau
Pacing and Clinical Electrophysiology : PACE|January 31, 2002
Early reinitiation of atrial fibrillation after electrical defibrillation: a new electrophysiological phenomenonC P Lau, H F Tse
Clinical and Experimental Pharmacology & Physiology|December 24, 1997
Electrical remodelling of chronic atrial fibrillationC P Lau, H F Tse
Chest|February 1, 1995
Exercise-associated cardiac asystole in persons without structural heart diseaseH F Tse, C P Lau
Journal of Cardiovascular Pharmacology|August 1, 1996
Relative efficacy and tolerability of lacidipine and amlodipine in patients with mild-to-moderate hypertension: a randomized double-blind studyC P Lau, B M Cheung
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|September 18, 1999
Dual chamber implantable cardioverter defibrillator benefits and limitationsK Fan, K Lee, C P Lau
Heart and Vessels|January 1, 1992
Acute hemorrhagic myocarditis in systemic lupus erythematosusP Dickens, J Nicholls, C P Lau
Pageof 29

Showing results (31-40 of 287) with videos related to

Sort By:
Pageof 29
British Journal of Clinical Pharmacology|April 6, 1999
Fosinopril reduces left ventricular mass in untreated hypertensive patients: a controlled trialB M Cheung, C P Lau
The American Journal of Cardiology|November 1, 1988
Role of left ventricular function and Doppler-derived variables in predicting hemodynamic benefits of rate-responsive pacingC P Lau, A J Camm
Chinese Medical Journal|March 27, 2001
Atrial sensing and pacing with a single pass ventricular leadH F Tse, C P Lau
Current Cardiology Reports|October 17, 2001
Should all implantable cardioverter defibrillators for ventricular arrhythmias be dual-chamber devices?K L Lee, C P Lau
Pacing and Clinical Electrophysiology : PACE|January 31, 2002
Early reinitiation of atrial fibrillation after electrical defibrillation: a new electrophysiological phenomenonC P Lau, H F Tse
Clinical and Experimental Pharmacology & Physiology|December 24, 1997
Electrical remodelling of chronic atrial fibrillationC P Lau, H F Tse
Chest|February 1, 1995
Exercise-associated cardiac asystole in persons without structural heart diseaseH F Tse, C P Lau
Journal of Cardiovascular Pharmacology|August 1, 1996
Relative efficacy and tolerability of lacidipine and amlodipine in patients with mild-to-moderate hypertension: a randomized double-blind studyC P Lau, B M Cheung
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|September 18, 1999
Dual chamber implantable cardioverter defibrillator benefits and limitationsK Fan, K Lee, C P Lau
Heart and Vessels|January 1, 1992
Acute hemorrhagic myocarditis in systemic lupus erythematosusP Dickens, J Nicholls, C P Lau
Pageof 29